Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, 2011-2012
Overview
Affiliations
The overall prevalence of hypertension has not changed appreciably since 2009-2010. The age-adjusted prevalence of hypertension among U.S. adults was 29.1% in 2011-2012. Among adults with hypertension in 2011-2012, 82.8% were aware of their hypertension, 75.7% were currently taking medication to lower their blood pressure, and 51.9% had their blood pressure controlled to less than 140/90 mm Hg. Men and women had similar prevalence and awareness of hypertension, but more women than men were treating their hypertension and had it under control. Young adults aged 18-39 continued to have lower awareness, treatment, and control of their hypertension compared with older adults. Hypertension prevalence was still highest among non-Hispanic black adults. However, awareness, treatment, and control of hypertension were similar among non-Hispanic black, non-Hispanic white, and Hispanic adults. Non-Hispanic Asian adults had a lower prevalence of awareness than the other race and Hispanic origin groups, and lower treatment than non-Hispanic white and non-Hispanic black adults. However, hypertension control was similar among non-Hispanic Asian adults and the other race and Hispanic origin groups. Hypertension is a common and manageable chronic condition. Based on recent national data from 2011-2012, treatment of hypertension exceeded the Healthy People 2020 target goal of 69.5%. However, the control of hypertension has neither met the goal of the Healthy People 2020 (61.2% by 2020) nor the Million Hearts Initiative (65% by 2017). These results provide evidence for continued efforts to improve the management of hypertension in order to attain these goals.
Jalo R, Bamgboye E, Salawu M, Akinyemi J, Uja U, Ogah O BMC Cardiovasc Disord. 2025; 25(1):151.
PMID: 40045189 PMC: 11883994. DOI: 10.1186/s12872-025-04603-0.
Factors predicting secondary hypertension in young adults with hypertension: a retrospective study.
Prasert N, Manosroi W, Hankamolsiri B, Wae-Uma M, Choonklai P BMC Cardiovasc Disord. 2025; 25(1):57.
PMID: 39871170 PMC: 11771069. DOI: 10.1186/s12872-025-04520-2.
Elhamdani A, Vashistha K, Alhuneafat L, Altarawneh T, Biederman R, Wilson J Future Cardiol. 2025; 21(3):149-153.
PMID: 39846891 PMC: 11875496. DOI: 10.1080/14796678.2025.2457933.
Schubel L, Barac A, Magee M, Mete M, Peeples M, Shomali M Contemp Clin Trials Commun. 2025; 43():101387.
PMID: 39810843 PMC: 11732108. DOI: 10.1016/j.conctc.2024.101387.
Sex differences in gut microbiota, hypertension, and cardiovascular risk.
Sharma A, Kapur S, Kancharla P, Yang T Eur J Pharmacol. 2024; 987():177183.
PMID: 39647571 PMC: 11714433. DOI: 10.1016/j.ejphar.2024.177183.